Who is it? | Physician & Surgeon |
Birth Day | September 22, 1901 |
Birth Place | Halifax, Nova Scotia, American |
Age | 119 YEARS OLD |
Died On | January 12, 1997(1997-01-12) (aged 95)\nChicago, Illinois |
Birth Sign | Libra |
Citizenship | Canadian / American |
Alma mater | Acadia University Harvard University |
Known for | prostate cancer hormones |
Awards | Nobel Prize for Physiology or Medicine (1966) Gairdner Foundation International Award (1966) |
Fields | physiology |
Institutions | University of Michigan, University of Chicago |
Charles Brenton Huggins, an accomplished physician and surgeon in American medical history, is projected to have a net worth ranging between $100,000 and $1 million by the year 2024. Throughout his career, Huggins made significant contributions to the field of medicine, particularly in the study and treatment of various cancers. He was awarded the Nobel Prize in Physiology or Medicine in 1966 for his groundbreaking research on hormone therapy for prostate cancer. Huggins' expertise and numerous accolades have undoubtedly paved the way for his financial success in the medical profession.
Huggins was born in Halifax, Nova Scotia, Canada. He graduated from Acadia University with a BA degree in 1920. He went on to study Medicine at Harvard Medical School and received his MD degree in 1924. He served his internship and residency in general surgery with Frederick A. Coller at the University of Michigan.
Huggins established a method to measure the effect hormone changes have on prostatic function. He found out that castration or estrogen administration led to glandular atrophy, which could be reversed by re-administration of androgen. In 1941 the beneficial effect of androgen ablation on metastatic prostate cancer was realised when Huggins and Clarence Hodges treated patients by either castration or estrogen therapy. They monitored the prostate size and therapeutic efficacy by measuring serum prostatic acid phosphatase levels and concluded that androgenic activity in the body influences prostate cancer, at least with respect to serum phosphatase. Huggins was the first to use a systemic approach to treat prostate cancer.
Huggins was awarded the Nobel Prize in Physiology or Medicine in 1966.
Huggins died 1997 in Chicago, Illinois at the age of 95 years. His wife died in 1983.